These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32885039)

  • 21. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.
    Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D
    J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting Cognitive Decline in Parkinson's Disease with Mild Cognitive Impairment: A One-Year Observational Study.
    Chen PH; Cheng FY; Cheng SJ; Shaw JS
    Parkinsons Dis; 2020; 2020():8983960. PubMed ID: 33178412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment.
    Samat NA; Abdul Murad NA; Mohamad K; Abdul Razak MR; Mohamed Ibrahim N
    Front Neurosci; 2017; 11():712. PubMed ID: 29326545
    [No Abstract]   [Full Text] [Related]  

  • 25. Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.
    Nicoletti A; Luca A; Baschi R; Cicero CE; Mostile G; Davì M; La Bianca G; Restivo V; Zappia M; Monastero R
    J Neurol; 2021 Feb; 268(2):549-558. PubMed ID: 32865628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
    Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
    Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment.
    Becker S; Boettinger O; Sulzer P; Hobert MA; Brockmann K; Maetzler W; Berg D; Liepelt-Scarfone I;
    J Alzheimers Dis; 2021; 79(1):197-209. PubMed ID: 33216023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Grey matter atrophy in cognitively impaired Parkinson's disease.
    Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pro-Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE-PD.
    Stuart S; Lawson RA; Yarnall AJ; Nell J; Alcock L; Duncan GW; Khoo TK; Barker RA; Rochester L; Burn DJ;
    Mov Disord; 2019 Nov; 34(11):1690-1698. PubMed ID: 31442355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.
    Delgado-Alvarado M; Gago B; Navalpotro-Gomez I; Jiménez-Urbieta H; Rodriguez-Oroz MC
    Mov Disord; 2016 Jun; 31(6):861-81. PubMed ID: 27193487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.